377 related articles for article (PubMed ID: 26051531)
1. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.
Mohanty S; Mohanty P; Trivedi C; Gianni C; Bai R; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Hranitzky PM; Al-Ahmad A; Bailey S; Di Biase L; Natale A
Heart Rhythm; 2015 Sep; 12(9):1963-71. PubMed ID: 26051531
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
[TBL] [Abstract][Full Text] [Related]
3. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
[TBL] [Abstract][Full Text] [Related]
6. Precise Drug Sequential Therapy Can Improve the Cardioversion Rate of Atrial Fibrillation with Valvular Disease after Radiofrequency Ablation.
Li T; Qian Y
Methods Mol Biol; 2020; 2204():145-159. PubMed ID: 32710322
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
8. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction.
Zhao Y; Di Biase L; Trivedi C; Mohanty S; Bai R; Mohanty P; Gianni C; Santangeli P; Horton R; Sanchez J; Gallinghouse GJ; Zagrodzky J; Hongo R; Beheiry S; Lakkireddy D; Reddy M; Hranitzky P; Al-Ahmad A; Elayi C; Burkhardt JD; Natale A
Heart Rhythm; 2016 Jan; 13(1):141-9. PubMed ID: 26304713
[TBL] [Abstract][Full Text] [Related]
9. Left Atrial Reverse Remodeling After Catheter Ablation of Nonparoxysmal Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction.
Oka T; Inoue K; Tanaka K; Ninomiya Y; Hirao Y; Tanaka N; Okada M; Inoue H; Nakamaru R; Koyama Y; Okamura A; Iwakura K; Sakata Y; Fujii K
Am J Cardiol; 2018 Jul; 122(1):89-96. PubMed ID: 29703439
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
[TBL] [Abstract][Full Text] [Related]
11. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study.
Bhargava M; Di Biase L; Mohanty P; Prasad S; Martin DO; Williams-Andrews M; Wazni OM; Burkhardt JD; Cummings JE; Khaykin Y; Verma A; Hao S; Beheiry S; Hongo R; Rossillo A; Raviele A; Bonso A; Themistoclakis S; Stewart K; Saliba WI; Schweikert RA; Natale A
Heart Rhythm; 2009 Oct; 6(10):1403-12. PubMed ID: 19716348
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of left ventricular diastolic function to predict recurrence of atrial fibrillation in patients with preserved left ventricular systolic function.
Hirai T; Cotseones G; Makki N; Agrawal A; Wilber DJ; Barron JT
Am J Cardiol; 2014 Jul; 114(1):65-9. PubMed ID: 24819904
[TBL] [Abstract][Full Text] [Related]
14. Impact of atrial fibrillation ablation on left ventricular filling pressure and left atrial remodeling.
Santos SN; Henz BD; Zanatta AR; Barreto JR; Loureiro KB; Novakoski C; Santos MV; Giuseppin FF; Oliveira EM; Leite LR
Arq Bras Cardiol; 2014 Dec; 103(6):485-92. PubMed ID: 25590928
[TBL] [Abstract][Full Text] [Related]
15. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study.
Nührich JM; Steven D; Berner I; Rostock T; Hoffmann B; Servatius H; Sultan A; Lüker J; Treszl A; Wegscheider K; Willems S
Heart Rhythm; 2014 Sep; 11(9):1536-42. PubMed ID: 24907643
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.
Hanna IR; Heeke B; Bush H; Brosius L; King-Hageman D; Dudley SC; Beshai JF; Langberg JJ
Heart Rhythm; 2006 Aug; 3(8):881-6. PubMed ID: 16876733
[TBL] [Abstract][Full Text] [Related]
17. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control.
Nedios S; Sommer P; Dagres N; Kosiuk J; Arya A; Richter S; Gaspar T; Kanagkinis N; Dinov B; Piorkowski C; Bollmann A; Hindricks G; Rolf S
Heart Rhythm; 2014 Mar; 11(3):344-51. PubMed ID: 24374320
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function.
Anselmino M; Grossi S; Scaglione M; Castagno D; Bianchi F; Senatore G; Matta M; Casolati D; Ferraris F; Cristoforetti Y; Negro A; Gaita F
J Cardiovasc Electrophysiol; 2013 Jan; 24(1):24-32. PubMed ID: 23140485
[TBL] [Abstract][Full Text] [Related]
20. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.
Cha YM; Wokhlu A; Asirvatham SJ; Shen WK; Friedman PA; Munger TM; Oh JK; Monahan KH; Haroldson JM; Hodge DO; Herges RM; Hammill SC; Packer DL
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):724-32. PubMed ID: 21747059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
